Table 2.
Effect on the number of oncological resections
| Cancer type | n | Annual number of resections before COVID-19 (average of last 3 years), median (IQR) | n | Reduction of resections (in %), mean (±SD) |
|---|---|---|---|---|
| Pancreatic cancer | 64 | 28 (10–50) | 66 | 31.6 (±35.4) |
| Oesophageal cancer | 59 | 8 (0–20) | 60 | 19.0 (±32.1) |
| Gastric cancer | 58 | 30 (20–50) | 60 | 27.4 (±33.5) |
| Colorectal cancer | 59 | 110 (60–205) | 61 | 30.0 (±30.3) |
| Hepatic cancer and hepatic metastasis | 57 | 20 (5–50) | 60 | 32.8 (±36.4) |
| Bile duct cancer | 61 | 10 (5–15) | 62 | 33.8 (±39.5) |
| Neuroendocrine tumours | 57 | 10 (5–20) | 61 | 30.2 (±39.4) |
IQR, interquartile range; SD, standard deviation; n, number of answers given.